News & Updates

Trust improves uptake of adjuvant endocrine therapy in breast cancer
Trust improves uptake of adjuvant endocrine therapy in breast cancer
27 Nov 2022

Breast cancer patients with a more trustful bond with their physicians appear to be more open to taking adjuvant endocrine therapy (AET) and show lower concerns regarding the treatment, a recent study has found.

Trust improves uptake of adjuvant endocrine therapy in breast cancer
27 Nov 2022
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
Immunosuppressant exposure tied to guideline-congruent cervical cancer screening
24 Nov 2022
Which factors raise HCC risk in patients with cured HCV?
Which factors raise HCC risk in patients with cured HCV?
24 Nov 2022 byStephen Padilla

Predictors of hepatocellular carcinoma (HCC) differ in patients with virologically cured hepatitis C virus (HCV) infection with and without cirrhosis, according to a study. However, changes in fibrosis-4 (FIB-4) scores over time are associated with HCC risk in both cohorts.

Which factors raise HCC risk in patients with cured HCV?
24 Nov 2022
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022 byStephen Padilla

In patients with solitary metastatic recurrences of prostate cancer, metastasis-directed therapy (MDT without androgen deprivation therapy (ADT) can lead to delayed initiation of systemic therapy, according to a study.

MDT without ADT delays systemic therapy initiation in recurrent prostate cancer
21 Nov 2022